Lidia Ruiz Tabuenca

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

[GESIDA Consensus document on the use of resistance studies in clinical practice].

Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC.

Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.